Adamas Biotech Srl

Adamas Biotech Srl is a clinical stage company based in Italy, founded in 2018. The company is dedicated to advancing the state-of-the-art in nature-based healthcare solutions. Specializing in the development of bioactive molecules derived from botanicals, particularly green tea catechins, Adamas Biotech is pioneering nutraceutical-based prophylactic and therapeutic solutions for a range of clinical and wellness indications. Their initial pipeline focuses on 100% natural formulations of green tea purified compounds, being developed for applications in cancer prevention, anti-aging, wound care, and sports medicine. The company recently received a €120.00K Corporate Round investment on 09 May 2023, with funding from Cube Labs and Istituto Nazionale Biostrutture e Biosistemi. With its innovative approach to developing natural health solutions, Adamas Biotech is well-positioned to make significant strides in the Biotechnology, Health Care, and Pharmaceutical industries. Its focus on leveraging the power of botanicals for healthcare applications presents promising opportunities for growth and impact, making it an intriguing prospect for potential investors.